JPRN-UMIN000008130已完成未知
Feasibility study of the combination of cisplatin and docetaxel with concurrent thoracic radiotherapy for locally advanced resectable non-small cell lung cancer. - Feasibility study of the combination of cisplatin and docetaxel with concurrent thoracic radiotherapy for locally advanced resectable non-small cell lung cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Presence of malignant pleural effusion or malignant pericardial fluid Presence of pleural dissemination Presence of active double cancers Even in the case of asynchronous double cancers, the patient will be excluded if there is a past history of chemotherapy or thoracic radiotherapy. Presence of serious complications 1)Interstitial pneumonia 2)Serious heart disease (e.g., difficult to control angina pectoris, myocardial infarction within the past 3 months, etc.) 3)Difficult to control diabetes mellitus 4)Serious infection 5)Presence of any other complications which can be thought to represent a serious impediment to performance of the therapy Pregnancy, breast feeding or the intention to become pregnant
研究者
相似试验
招募中
2 期
A phase II study of Conbination therapy of Cisplatin/Pemetrexed/Bavacizumab in previously untreated patients with StageIIIB/IV or recurrent disease nonsquamous non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000006874Fukushima medical University37
已完成
1 期
Phase Ib study of combination therapy with Cisplatin, Irinotecan, and Ramucirumab for extensive-disease small-cell lung cancerExtensive disease small cell lung cancerJPRN-UMIN000032671Shizuoka Cancer Center10
招募中
2 期
Efficacy and safety of the combination of Cisplatin plus Nab-paclitaxel and Nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle
invasive Bladder Cancer. (CA209-6E8, CNN-BC trial)2024-518937-26-00Fondazione Policlinico Universitario Agostino Gemelli IRCCS24
尚未招募
不适用
Comparative response evaluation of Cisplatin-Capecitabine with Cisplatin-5-Fluorouracil in advanced gastric carcinoma.Clinically diagnosed and histopathologically proved advanced gastric carcinoma (AJCC Stage IV).Advanced gastric carcinoma.TCTR20170715001Bangabandhu Sheikh Mujib Medical University62
已完成
不适用
Feasibility study of moderate dose of cisplatin-based chemotherapy with ultrashort hydration for advanced lung canceradvanced lung cancerJPRN-UMIN000015533Okayama Lung Cancer Study Group45